Everolimus Related Pneumonitis in MBC

Updated 06/21/2024

Status Completed

Clinical Trial Summary

To study the drug-related pneumonitis during mTOR inhibitor therapy in patients with metastatic breast cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03730428
Study type	Observational
Source	Fudan University
Contact
Status	Completed
Phase
Start date	July 15, 2017
Completion date	June 15, 2020

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02246361` - Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication	Phase 4
	Completed	`NCT00997555` - Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients	N/A
	Recruiting	`NCT05280873` - Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP	Phase 1
	Completed	`NCT00081315` - Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer	Phase 2
	Active, not recruiting	`NCT04590547` - GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)	Phase 2
	Terminated	`NCT04370834` - Tocilizumab for Patients With Cancer and COVID-19 Disease	Phase 2
	Completed	`NCT02788643` - Study of Collagen IV and XIX in Bronchoalveolar Lavage, Pulmonary Aspiration and Bronchial Biopsies
	Active, not recruiting	`NCT04326725` - Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia
	Completed	`NCT03012958` - Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
	Completed	`NCT04721444` - Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19)
	Terminated	`NCT04040244` - Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis	N/A
	Completed	`NCT04302688` - Accurate Classification System for Patients With COVID-19 Pneumonitis
	Terminated	`NCT03962725` - Avoiding Neuromuscular Blockers to Reduce Complications	Phase 4
	Recruiting	`NCT05455034` - Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis	Phase 1/Phase 2